Table 3 Bivariate logistic regression of predisposing factors with TB in HIV patients.
Characteristic | Number (%) | TB (%) | Odds ratio (95%CI) | P-value |
|---|---|---|---|---|
Age | ||||
≤ 30 | 18 (17.1) | 1(5.6) | 0.559(0.046–6.727) | 0.647 |
31–50 | 64 (62.5) | 3 (4.7) | 0.467(0.073–3.007) | 0.423 |
≥ 51 | 24 (20.4) | 2 (9.5) | Reference | |
Gender | ||||
Female | 62 (60.2) | 02 (3.2) | Reference | |
Male | 41 (39.8) | 04 (9.8) | 1.980 (0.580–6.755) | 0.275 |
Religion | ||||
Catholic | 34 (33.0) | 04 (11.8) | Reference | |
Anglican | 28 (27.2) | 02 (7.1) | 0.714 (0.179–2.847) | 0.633 |
Moslems | 23 (22.3) | 00 (00) | 1.143 (0.129–8.436) | 0.968 |
Pentecost | 18 (17.5) | 00 (00) | 2.234 (0.322–15.515 | 0.416 |
Marital status | ||||
Divorced/separated | 22 (21.4) | 01 (4.5) | Reference | |
Lives with partner | 28 (26.3) | 02 (3.4) | 0.171 (0.045–0.697) | 0.014 |
Single | 11 (10.7) | 01 (9.0) | 1.143 (0.124–8.512) | 0.896 |
Widowed | 12 (11.6) | 02 (16.7) | 2.047 (0.341–12.285 | 0.433 |
Education | ||||
None | 11 (10.7) | 00 (00) | Reference | |
Tertiary | 27 (26.2) | 00 (00) | 1.835 (0.192–17.494) | 0.598 |
Secondary | 37 (35.9) | 03 (8.1) | 0.877 (0.102–7.568) | 0.905 |
Primary | 28 (27.2) | 03 (10.7) | 2.224 (0.334–14.385 | 0.401 |
Residence | ||||
Rural | 15 (14.6 | 00 (00) | Reference | |
Urban | 54 (52.4) | 06 (11) | 1.758 (0.728–4.242) | 0.209 |
Sub-urban | 34 (33) | 00 (00) | 0.843 (0.428–1.659) | 0.621 |
Employment | ||||
Unemployed | 44 (42.7) | 04 (9.1) | Reference | |
Employed | 59 (57.3) | 02 (3.4) | 3.326 (0.824–13.417) | 0.091 |
Alcohol use | ||||
No | 56 (54.4) | 00 (00) | Reference | |
Yes | 47 (45.6) | 06 (10.7) | 2.402 (0.421–13.700) | 0.324 |
Smoking | ||||
Non-smoker | 96 (93.2) | 05 (5.2) | Reference | |
Smoker | 07 (6.8) | 01 (14.3) | 1.648 (0.183–14.876) | 0.656 |
Disclosure | ||||
Not disclosed | 27 (26.2) | 04 (14.8) | Reference | |
Disclosed | 76 (73.8) | 02 (2.6) | 0.181 (0.335–4.164) | 0.795 |
Awareness of IPT as preventive measure against TB | ||||
No | 24 (23.3) | 05 (20.8) | Reference | |
Yes | 79 (76.7) | 01 (1.3) | 0.455 (0.109–1.905) | 0.482 |
Side effects | ||||
Not affected | 57 (55.3) | 00 (00) | Reference | |
Affected | 46 (44.7) | 06 (13) | 1.068 (0.315–3.618) | 0.916 |
Pill burden | ||||
Not burdensome | 61 (59.2) | 00 (00) | Reference | |
Burdensome | 42 (40.8) | 06 (14.3) | 1.100 (0.220–5.503) | 0.908 |
Stigma | ||||
Not stigmatized | 70 (68.0) | 00 (00) | Reference | |
Stigmatized | 33 (32.0) | 06 (18.2) | 1.029 (0.170–3.123) | 0.670 |
Adherence counselling | ||||
Not counselled | 41 (39.8) | 04 (9.8) | Reference | |
Counselled | 62 (60.2) | 02 (3.2) | 0.013 (0.01–0.175) | 0.001 |
